Serum vascular adhesion protein-1 level predicts risk of incident cancers in subjects with type II diabetes
Journal
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
Journal Volume
23
Journal Issue
7
Pages
1366
Date Issued
2014-07
Author(s)
Yu, Tse-Ya
TIEN-JYUN CHANG
Wei, Jung-Nan
Lin, Chi-Ming
Chu, Ching-Chi
LEE-MING CHUANG
Abstract
Serum vascular adhesion protein-1 (VAP-1) predicts cancer-related mortality in diabetic subjects. However, whether serum VAP-1 predicts cancer incidence or cancer progression remains unclear. We conducted a cohort study to investigate whether serum VAP-1 and related clinical variables predict incident cancers in type II diabetic subjects.
Subjects
CHRONIC KIDNEY-DISEASE; SENSITIVE AMINE OXIDASE; COLORECTAL-CANCER; PROSTATE-CANCER; INFLAMMATION; ASSOCIATION; PROGRESSION; MORTALITY; METASTASES; MOLECULE
Publisher
AMER ASSOC CANCER RESEARCH
Type
journal article